Q&A: ‘Put patients before profits’ to beat drug resistance
Ruth Douglas interviews Jayasree K. Iyer about the growing threat of antimicrobial resistance (AMR). She explores the Access to Medicine Foundation’s AMR Benchmark, and takes a look at what steps the pharmaceutical industry and governments should be taking to curb the threat.